Nordea Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Nordea Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,156	Closed	-$231K	–	998
2021 Q1	$231K	Hold	5,156	–	–	﹤0.01%	962
2020 Q4	$292K	Hold	5,156	–	–	﹤0.01%	909
2020 Q3	$252K	Sell	5,156 -5,156	-50%	-$286K	﹤0.01%	890
2020 Q2	$610K	Buy	10,312 +5,156	+100%	+$287K	﹤0.01%	859
2020 Q1	$247K	Hold	5,156	–	–	﹤0.01%	884
2019 Q4	$311K	Hold	5,156	–	–	﹤0.01%	917
2019 Q3	$309K	Hold	5,156	–	–	﹤0.01%	910
2019 Q2	$332K	Sell	5,156 -94,032	-95%	-$6.65M	﹤0.01%	918
2019 Q1	$8.05M	Sell	99,188 -3,122	-3%	-$201K	0.02%	432
2018 Q4	$5.53M	Sell	102,310 -3,667	-3%	-$187K	0.01%	476
2018 Q3	$5.47M	Buy	105,977 +38,663	+57%	+$1.82M	0.01%	529
2018 Q2	$2.81M	Buy	67,314 +7,554	+13%	+$335K	0.01%	692
2018 Q1	$2.63M	Buy	+59,760	New	+$3.04M	0.01%	692
2016 Q3	–	Sell	-2,173	Closed	-$51K	–	1026
2016 Q2	$51K	Hold	2,173	–	–	﹤0.01%	975
2016 Q1	$88K	Buy	2,173 +373	+21%	+$15.2K	﹤0.01%	916
2015 Q4	$111K	Hold	1,800	–	–	﹤0.01%	908
2015 Q3	$73K	Hold	1,800	–	–	﹤0.01%	891
2015 Q2	$104K	Hold	1,800	–	–	﹤0.01%	873
2015 Q1	$115K	Buy	+1,800	New	+$122K	﹤0.01%	788

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Nordea Investment Management's IONS Position: Q2 2021 in Review

Nordea Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 5,156 shares — an estimated $231K sold.

Nordea Investment Management first reported a position in IONS in Q1 2015 and held it in 19 quarters. The position peaked at $8.05M in Q1 2019. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Nordea Investment Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Nordea Investment Management sold 5,156 Ionis Pharmaceuticals shares in Q2 2021, an estimated $231K.
Nordea Investment Management first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 19 quarters.
Nordea Investment Management's Ionis Pharmaceuticals position peaked at $8.05M in Q1 2019.
337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Nordea Investment Management's 13F filing for Q2 2021, filed 16 Jul 2021.